最近の主要論文

1. Taniuchi S, Sakai R, Nishida T, Goma M, Mitomori M, Imade A, Enomoto M, Nishino M, Okizuka Y, Kido H. The combination of binding avidity of ovomucoid-specific IgE antibody and specific IgG4 antibody can predict positive outcomes of oral food challenges during stepwise slow oral immunotherapy in children with hen’s egg allergy.
   Nutrients 15:2770 (2023)
2. Nakamura K, Kouzaki H, Murao T, Kawakita K, Arai H, Matsumoto K, Kubo Y, Tojima I, Shimizu S, Ogawa Y, Yuta A, Sakai R, Ohno H, Kido H, Shimizu T. Sublingual immunotherapy decreases the avidity of antigen-specific IgE in patients with Japanese cedar pollinosis.
   Allergy 78(12):3268-71(2023)
3. Takahashi E, Sawabuchi T, Homma T, Fukuda Y, Sagara H, Kinjo T, Fujita K, Suga S, Kimoto T, Sakai S, Kameda K, Kido H. Clinical utility of SARS-CoV-2 antibody titer multiplied by binding avidity of receptor-binding domain (RBD) in monitoring protective immunity and clinical severity.
   Viruses 15(8):1662(2023)
4. Kimoto T, Kim H, Sakai S, Takahashi E, Kido H. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice.
   Vaccine 37:612-622 (2019)

5. Natsume O, Kabashima S, Nakazato J, Yamamoto-Hanada K, Narita M, Kondo M, Saito M, Kishino A, Takimoto T, Inoue E, Tang J, Kido H, Wong GW, Matsumoto K, Saito H, Ohya Y; PETIT Study Team. Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): A randomized, double-blind, placebo-controlled trial.
   Lancet. 389: 276-86 (2017)

6. Kido H. Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options.
   Proc Jpn Acad Ser B Phys Biol Sci. 91: 351-68 (2015)